{"disease":{"id":"von-willebrand-disease-vwd","name":"von willebrand disease vwd"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06710262","title":"T-TAS® wS Method Comparison","phase":"","overall_status":"COMPLETED","enrollment_count":115,"lead_sponsor_name":"Hikari Dx, Inc.","has_results":false},{"nct_id":"NCT05265078","title":"A Study on Estimated Risks of Certain Adverse Events in Adults With Von Willebrand Disease (VWD) Treated With Veyvondi","phase":"","overall_status":"COMPLETED","enrollment_count":102,"lead_sponsor_name":"Takeda","has_results":false},{"nct_id":"NCT07358013","title":"Endothelial Colony-Forming Cells in Patients With VWD, AVWS and Healthy Subjects","phase":"","overall_status":"RECRUITING","enrollment_count":48,"lead_sponsor_name":"Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico","has_results":false},{"nct_id":"NCT03879135","title":"A Study of Recombinant Von Willebrand Factor (rVWF) in Pediatric and Adult Participants With Severe Von Willebrand Disease (VWD)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":38,"lead_sponsor_name":"Baxalta now part of Shire","has_results":true},{"nct_id":"NCT06433778","title":"A Study on the Outcomes of Recombinant Von Willebrand Factor on Demand Treatment and Prevention and Treatment of Bleeding During and After Surgery in Adults With Inherited Von Willebrand Disease in the United Kingdom (UK)","phase":"","overall_status":"COMPLETED","enrollment_count":34,"lead_sponsor_name":"Takeda","has_results":false},{"nct_id":"NCT05582993","title":"A Study of Vonicog Alfa (rVWF) in Children With Severe Von Willebrand Disease (vWD)","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":24,"lead_sponsor_name":"Takeda","has_results":false},{"nct_id":"NCT07129343","title":"A Study of Recombinant Von Willebrand Factor (rVWF) in Chinese Participants With Von Willebrand Disease (vWD)","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":20,"lead_sponsor_name":"Takeda","has_results":false},{"nct_id":"NCT07404644","title":"An Observational Study of Vonicog Alfa (rVWF) in Pediatric Participants With Von Willebrand Disease (vWD)","phase":"","overall_status":"RECRUITING","enrollment_count":13,"lead_sponsor_name":"Takeda","has_results":false},{"nct_id":"NCT05695560","title":"A Survey to Describe the Experience and Unmet Needs of Persons Living With Von Willebrand Disease (VWD) and Their Caregivers","phase":"","overall_status":"COMPLETED","enrollment_count":12,"lead_sponsor_name":"Takeda","has_results":false},{"nct_id":"NCT07273721","title":"Efficacy and Safety of BT200 (Rondaptivon Pegol) in Patients With Type 2B Von Willebrand Disease","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":6,"lead_sponsor_name":"Medical University of Vienna","has_results":false},{"nct_id":"NCT04770935","title":"To Assess the Pharmacokinetics and Safety and Tolerability of Efanesoctocog Alfa (BIVV001)in Adults With Type 2N and 3 Von Willebrand Disease (VWD)","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":6,"lead_sponsor_name":"Bioverativ, a Sanofi company","has_results":false},{"nct_id":"NCT06173024","title":"Post Trial Access Program of TAK-577 for Von Willebrand Disease (VWD)","phase":"","overall_status":"AVAILABLE","enrollment_count":null,"lead_sponsor_name":"Takeda","has_results":false}],"total":12},"guidelines":[],"source":"Drug Landscape verified database"}